EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Low‐dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe‐BIRD) in a child with relapsed/refractory B‐cell acute lymphoblastic leukemia with TP53 mutation

Vivek Mohan iD, Sachin Jain, Rahul Naithani iD

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.31152 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Vivek Mohan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Bone Marrow Transplant, Paras Health, Gurugram, Haryana, India. Hauptthemen laut MEDLINE: Bridged Bicyclo Compounds, Heterocyclic, Antineoplastic Combined Chemotherapy Protocols, Dexamethasone, Bortezomib. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bridged Bicyclo Compounds, HeterocyclicAntineoplastic Combined Chemotherapy ProtocolsDexamethasoneBortezomibRituximabMutationSulfonamidesPrecursor B-Cell Lymphoblastic Leukemia-LymphomaHumansTumor Suppressor Protein p53Inotuzumab OzogamicinChildMaleNeoplasm Recurrence, LocalFemale

Substanzen

Bridged Bicyclo Compounds, HeterocyclicvenetoclaxDexamethasoneBortezomibRituximabSulfonamidesTP53 protein, humanTumor Suppressor Protein p53Inotuzumab Ozogamicin

Autor:innen und Institutionen

  • Department of Hematology and Bone Marrow Transplant, Paras Health, Gurugram, Haryana, India.

ORCID-Profile: Vivek Mohan, Rahul Naithani

Zitieren

APA

Mohan, V., Jain, S., & Naithani, R. (2024). Low‐dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe‐BIRD) in a child with relapsed/refractory B‐cell acute lymphoblastic leukemia with TP53 mutation. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31152

Vancouver

Mohan V, Jain S, Naithani R. Low‐dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe‐BIRD) in a child with relapsed/refractory B‐cell acute lymphoblastic leukemia with TP53 mutation. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31152

BibTeX
@article{Mohan2024,
  author = {Mohan, Vivek and Jain, Sachin and Naithani, Rahul},
  title = {Low‐dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe‐BIRD) in a child with relapsed/refractory B‐cell acute lymphoblastic leukemia with TP53 mutation},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.31152}
}
Kostenlos starten →